Theravance Biopharma
TBPH • NASDAQ
Theravance Biopharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Rick E. Winningham, with a market cap of $776.5M.
Market Cap$776.5M
Employees99.0
CEORick E. Winningham
CountryCayman Islands
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
TBP
Theravance Biopharma FAQ
Common questions about Theravance Biopharma
Theravance Biopharma is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $17.3M.
Theravance Biopharma has approximately 99 employees.